ORAMED PHARMACEUTICALS INC. (ORMP) — research page
US · us-cm-kg/NASDAQ/ORMP · as of 2026-11-08
Identity and listing
The issuer is ORAMED PHARMACEUTICALS INC., listed on NASDAQ under ticker ORMP, with ISIN US68403P2039 and LEI 5299006K52ZIIGQJ6R84. Its security type is Corporate, its segment is not on the record, its sector is 2834 Pharmaceutical Preparations, and its jurisdiction is United States, Delaware. Its listing status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | ORAMED PHARMACEUTICALS INC. | source · 2026-11-08 |
| exchange | NASDAQ | source · 2026-11-08 |
| ticker | ORMP | source · 2026-11-08 |
| ISIN | US68403P2039 | source · 2026-11-08 |
| LEI | 5299006K52ZIIGQJ6R84 | source · 2026-11-08 |
| security type | Corporate | source · 2026-11-08 |
| segment | not on the record | |
| sector | 2834 Pharmaceutical Preparations | source · 2026-11-08 |
| jurisdiction | United States — Delaware | source · 2026-11-08 |
| status | listed, not halted | source · 2026-11-08 |
The disclosure read
The record holds 63 filings in the twelve months from 2025-11-08 to 2026-11-08, across 34 filing days. The median gap between filing days is 6 days. The median latency from the latest filing to the record date is 37 days, against an exchange median of 5.0 days and a sector median of 4.0 days. The exchange median cadence gap is 6.0 days and the sector median cadence gap is 6.0 days. The latest filing is dated 2026-10-02 and is of type directors_dealings.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 63 | 6 | 37 |
| exchange median: NASDAQ (4359 issuers) | 52 | 6 | 5 |
| sector median: 2834 Pharmaceutical Preparations (526 issuers) | 63 | 6 | 4 |
| date | type | category | filing |
|---|---|---|---|
| 2026-10-02 | directors_dealings | 4 | 4 |
| 2026-10-02 | directors_dealings | 4 | 4 |
| 2026-10-01 | regulatory_filing | 144 | 144 |
| 2026-10-01 | regulatory_filing | 144 | 144 |
| 2026-09-25 | directors_dealings | 4 | 4 |
window 2025-11-08 to 2026-11-08 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is Kesselman & Kesselman C.P.A.s, located in Tel Aviv, Israel. The record holds no auditor changes.
Events and halts
The record holds one lifecycle line: a listing dated 2025-11-17. It holds no delisting, no name change, and no segment move. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag is listed, not halted.
Orderability
The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.
rule acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
No research houses were found on the issuer's own investor-relations pages read. The count is 0.
Open research
The record holds 8 openly published research notes. Zacks Small-Cap Research published 6 of them, dated 2022-11-21, 2022-04-28, 2021-11-10, 2020-12-10, 2020-01-07 and 2019-05-07. A.G.P. / Alliance Global Partners published one dated 2020-12-03. MLV published one dated 2014-01-07.
| date | publisher | note | kind |
|---|---|---|---|
| 2022-11-21 | Zacks Small-Cap Research | the note | issuer-sponsored |
| 2022-04-28 | Zacks Small-Cap Research | the note | issuer-sponsored |
| 2021-11-10 | Zacks Small-Cap Research | ORMP: Financing Enhances Flexibility to Advance Multiple Opportunities | issuer-sponsored |
| 2020-12-10 | Zacks Small-Cap Research | the note | issuer-sponsored |
| 2020-12-03 | A.G.P. / Alliance Global Partners | Oramed Pharmaceutical, Inc. | independent |
| 2020-01-07 | Zacks Small-Cap Research | ORMP: Multiple Data Readouts on the Horizon | issuer-sponsored |
| 2019-05-07 | Zacks Small-Cap Research | ORMP: Data from Phase 1 Trial of Oral GLP-1 in 2Q19… | issuer-sponsored |
| 2014-01-07 | MLV | Initiating Coverage | independent |
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The record holds sealed years 2021, 2022, 2023, 2024, 2025 and 2026 for this issuer. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.
Sources
17 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- 10.2
- https://mapping.gleif.org/api/v2/isin-lei/latest (identity.isin)
- 10.3
- https://data.sec.gov/submissions/CIK0001176309.json (identity.jurisdiction)
- 10.4
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- 10.5
- https://mcp.us-cm-kg.ai/events/NASDAQ/ORMP (the disclosure lines)
- 10.6
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- 10.7
- https://www.sec.gov/Archives/edgar/data/1176309/000121390026034835/ea0282618-10k_oramed.htm (the auditor)
- 10.8
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.9
- https://oramed.com/wp-content/uploads/2022/11/Zacks-Report-Nov.-2022.pdf (open research)
- 10.10
- https://oramed.com/wp-content/uploads/2022/06/Zacks-Report-April-28-2022.pdf (open research)
- 10.11
- https://oramed.com/wp-content/uploads/2022/06/Zacks_SCR_Research_November-11-2021.pdf (open research)
- 10.12
- https://oramed.com/wp-content/uploads/2022/06/Zacks-Update-Dec-2020-1.pdf (open research)
- 10.13
- https://oramed.com/wp-content/uploads/2022/06/AGP-initiating-coverage-ORMP-Dec-2020.pdf (open research)
- 10.14
- https://oramed.com/wp-content/uploads/2022/06/Zacks-Update-Jan-7-2020.pdf (open research)
- 10.15
- https://oramed.com/wp-content/uploads/2022/06/Zacks-SCR-Research-Update-May-2019.pdf (open research)
- 10.16
- https://oramed.com/wp-content/uploads/2022/06/MLV-Initiating-Coverage-7-Jan-2014.pdf (open research)
- 10.17
- https://mcp.us-cm-kg.ai/record/NASDAQ/ORMP (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getissuer.ai/mcp with {"isin":"US68403P2039"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:a583dd574eeabdda.